|
1
|
Lin D, Ma L, Ye T, Pan Y, Shao L, Song Z,
Jiang S, Chen H and Xiang J: Results of neoadjuvant therapy
followed by esophagectomy for patients with locally advanced
thoracic esophageal squamous cell carcinoma. J Thorac Dis.
9:318–326. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mao Y, Han Y and Shi W: The expression of
aplysia ras homolog I (ARHI) and its inhibitory effect on cell
biological behavior in esophageal squamous cell carcinoma. Onco
Targets Ther. 10:1217–1226. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cong L and Hu L: The value of the
combination of hemoglobin, albumin, lymphocyte and platelet in
predicting platinum-based chemoradiotherapy response in male
patients with esophageal squamous cell carcinoma. Int
Immunopharmacol. 46:75–79. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He Z, Li G, Tang L and Li Y: SIX1
overexpression predicts poor prognosis and induces radioresistance
through AKT signaling in esophageal squamous cell carcinoma. Onco
Targets Ther. 10:1071–1079. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiu B, Li J, Wang B, Wang Z, Liang Y, Cai
P, Chen Z, Liu M, Fu J, Yang H and Liu H: Adjuvant therapy for a
microscopically incomplete resection margin after an esophagectomy
for esophageal squamous cell carcinoma. J Cancer. 8:249–257. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morimoto H, Yano T, Yoda Y, Oono Y,
Ikematsu H, Hayashi R, Ohtsu A and Kaneko K: Clinical impact of
surveillance for head and neck cancer in patients with esophageal
squamous cell carcinoma. World J Gastroenterol. 23:1051–1058. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao Y, Ma K, Yang S, Zhang X, Wang F,
Zhang X, Liu H and Fan Q: MicroRNA-125a-5p enhances the sensitivity
of esophageal squamous cell carcinoma cells to cisplatin by
suppressing the activation of the STAT3 signaling pathway. Int J
Oncol. 53:644–658. 2018.PubMed/NCBI
|
|
8
|
Sugase T, Takahashi T, Serada S, Nakatsuka
R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki
Y, et al: Suppressor of cytokine signaling-1 gene therapy induces
potent antitumor effect in patient-derived esophageal squamous cell
carcinoma xenograft mice. Int J Cancer. 140:2608–2621. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xue L, Nan J, Dong L, Zhang C, Li H, Na R,
He H and Wang Y: Upregulated miR-483-5p expression as a prognostic
biomarker for esophageal squamous cell carcinoma. Cancer Biomark.
19:193–197. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie R, Wu SN, Gao CC, Yang XZ, Wang HG,
Zhang JL, Yan W and Ma TH: MicroRNA-30d inhibits the migration and
invasion of human esophageal squamous cell carcinoma cells via the
post-transcriptional regulation of enhancer of zeste homolog 2.
Oncol Rep. 37:1682–1690. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi Q, Wang Y, Mu Y, Wang X and Fan Q:
miR-433-3p inhibits proliferation and invasion of esophageal
squamous cell carcinoma by targeting GRB2. Cell Physiol Biochem.
46:2187–2196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li SP, Su HX, Zhao D and Guan QL: Plasma
miRNA-506 as a prognostic biomarker for esophageal squamous cell
carcinoma. Med Sci Monit. 22:2195–2201. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang C, Li Q, Liu F, Chen X, Nesa EU, Guan
S, Liu B, Han L, Tan B, Wang D, et al: Serum miR-1297: A promising
diagnostic biomarker in esophageal squamous cell carcinoma.
Biomarkers. 21:517–522. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guan S, Wang C, Chen X, Liu B, Tan B, Liu
F, Wang D, Han L, Wang L, Huang X, et al: miR-613: A novel
diagnostic and prognostic biomarker for patients with esophageal
squamous cell carcinoma. Tumour Biol. 37:4383–4391. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu H, Yao Y, Meng F, Qian X, Jiang X, Li
X, Gao Z and Gao L: Predictive value of serum miR-10b, miR-29c, and
miR-205 as promising biomarkers in esophageal squamous cell
carcinoma screening. Medicine (Baltimore). 94:e15582015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen W, Chen L, Zhang Z, Meng F, Huang G,
Sheng P, Zhang Z and Liao W: MicroRNA-455-3p modulates cartilage
development and degeneration through modification of histone H3
acetylation. Biochim Biophys Acta. 1863:2881–2891. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yao S, Tang B, Li G, Fan R and Cao F:
miR-455 inhibits neuronal cell death by targeting TRAF3 in cerebral
ischemic stroke. Neuropsychiatr Dis Treat. 12:3083–3092. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wong N, Khwaja SS, Baker CM, Gay HA,
Thorstad WL, Daly MD, Lewis JS Jr and Wang X: Prognostic microRNA
signatures derived from the cancer genome atlas for head and neck
squamous cell carcinomas. Cancer Med. 5:1619–1628. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chai L, Kang XJ, Sun ZZ, Zeng MF, Yu SR,
Ding Y, Liang JQ, Li TT and Zhao J: miR-497-5p, miR-195-5p and
miR-455-3p function as tumor suppressors by targeting hTERT in
melanoma A375 cells. Cancer Manag Res. 10:989–1003. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng J, Lin Z, Zhang L and Chen H:
MicroRNA-455-3p inhibits tumor cell proliferation and induces
apoptosis in HCT116 human colon cancer cells. Med Sci Monit.
22:4431–4437. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y
and Li L: MicroRNA-455-3p promotes invasion and migration in triple
negative breast cancer by targeting tumor suppressor EI24.
Oncotarget. 8:19455–19466. 2017.PubMed/NCBI
|
|
22
|
Chai J, Guo D, Ma W, Han D, Dong W, Guo H
and Zhang Y: A feedback loop consisting of
RUNX2/LncRNA-PVT1/miR-455 is involved in the progression of
colorectal cancer. Am J Cancer Res. 8:538–550. 2018.PubMed/NCBI
|
|
23
|
Liu J, Zhang J, Li Y, Wang L, Sui B and
Dai D: miR-455-5p acts as a novel tumor suppressor in gastric
cancer by down-regulating RAB18. Gene. 592:308–315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng CM, Shiah SG, Huang CC, Hsiao JR and
Chang JY: Up-regulation of miR-455-5p by the TGF-β-SMAD signalling
axis promotes the proliferation of oral squamous cancer cells by
targeting UBE2B. J Pathol. 240:38–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kotzsch M, Kirchner T, Soelch S, Schäfer
S, Friedrich K, Baretton G, Magdolen V and Luther T: Inverse
association of rab31 and mucin-1 (CA15-3) antigen levels in
estrogen receptor-positive (ER+) breast cancer tissues with
clinicopathological parameters and patients' prognosis. Am J Cancer
Res. 7:1959–1970. 2017.PubMed/NCBI
|
|
26
|
Pan Y, Zhang Y, Chen L, Liu Y, Feng Y and
Yan J: The critical role of Rab31 in cell proliferation and
apoptosis in cancer progression. Mol Neurobiol. 53:4431–4437. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sui Y, Zheng X and Zhao D: Rab31 promoted
hepatocellular carcinoma (HCC) progression via inhibition of cell
apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway. Tumour Biol.
36:8661–8670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Wu N, Zheng QF, Yan S, Lv C, Li SL
and Yang Y: Evaluation of the 7th edition of the TNM classification
in patients with resected esophageal squamous cell carcinoma. World
J Gastroentero. 20:18397–18403. 2014. View Article : Google Scholar
|
|
29
|
Ke W, Zeng L, Hu Y, Chen S, Tian M and Hu
Q: Detection of early-stage extrahepatic cholangiocarcinoma in
patients with biliary strictures by soluble B7-H4 in the bile. Am J
Cancer Res. 8:699–707. 2018.PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang W, Hong R, Xue L, Ou Y, Liu X, Zhao
Z, Xiao W, Dong D, Dong L and Fu M: Piccolo mediates EGFR signaling
and acts as a prognostic biomarker in esophageal squamous cell
carcinoma. Oncogene. 36:3890–3902. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mei LL, Qiu YT, Zhang B and Shi ZZ:
MicroRNAs in esophageal squamous cell carcinoma: Potential
biomarkers and therapeutic targets. Cancer Biomark. 19:1–9. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meng X, Chen X, Lu P, Ma W, Yue D, Song L
and Fan Q: miR-202 promotes cell apoptosis in esophageal squamous
cell carcinoma by targeting HSF2. Oncol Res. 25:215–223. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yi J, Jin L, Chen J, Feng B, He Z, Chen L
and Song H: miR-375 suppresses invasion and metastasis by direct
targeting of SHOX2 in esophageal squamous cell carcinoma. Acta
Biochim Biophys Sin (Shanghai). 49:159–169. 2017.PubMed/NCBI
|
|
35
|
Ren Y, Chen Y, Liang X, Lu Y, Pan W and
Yang M: miRNA-638 promotes autophagy and malignant phenotypes of
cancer cells via directly suppressing DACT3. Cancer Lett.
390:126–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang J, Wang Y, Sun D, Bu J, Ren F, Liu B,
Zhang S, Xu Z, Pang S and Xu S: miR-455-5p promotes cell growth and
invasion by targeting SOCO3 in non-small cell lung cancer.
Oncotarget. 8:114956–114965. 2017.PubMed/NCBI
|
|
37
|
Grismayer B, Sölch S, Seubert B, Kirchner
T, Schäfer S, Baretton G, Schmitt M, Luther T, Krüger A, Kotzsch M
and Magdolen V: Rab31 expression levels modulate tumor-relevant
characteristics of breast cancer cells. Mol Cancer. 11:622012.
View Article : Google Scholar : PubMed/NCBI
|
